• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR144-3p 通过 Tie2 抑制 PMVECs 在肝肺综合征血管生成中的过度增殖。

miR144-3p inhibits PMVECs excessive proliferation in angiogenesis of hepatopulmonary syndrome via Tie2.

机构信息

Department of Anesthesiology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.

Department of Developmental Neuropsychology, School of Psychology, Third Military Medical University, Chongqing 400038, China.

出版信息

Exp Cell Res. 2018 Apr 1;365(1):24-32. doi: 10.1016/j.yexcr.2018.02.009. Epub 2018 Feb 15.

DOI:10.1016/j.yexcr.2018.02.009
PMID:29453975
Abstract

BACKGROUND/AIM: Increasing evidence show microRNAs (miRNAs) are associated with hepatopulmonary syndrome (HPS). The aim of this study was to investigate the role of miR-144 in the angiogenesis of HPS, as well as to identify its underlying mechanism.

METHODS

The expression levels of miR-144-3p were assessed in pulmonary micro-vascular endothelial cells (PMVECs), as well as in lung tissues from rats with HPS. We predicted the potential target of miR-144-3p. Tyrosine kinase 2(Tie2) was identified as a target gene of miR144-3p, which has an essential role in the angiogenesis of lung vessel. In addition, the effects of miR-144-3p regulated on Tie2 was examined. The upregulation and down-regulation of miR-144-3p can affect the proliferation of PMVECs.

RESULTS

We found that the levels of miR-144-3p were frequently downregulated in HPS tissues and cell lines, and overexpression of miR-144-3p dramatically inhibited PMVECs proliferation and cell cycle. We further verified the Tie2 as a novel and direct target of miR-144-3p in HPS.

CONCLUSION

miR-144-3p can negatively regulate PMVECs proliferation by Tie2 expression. In addition, overexpression of miR-144-3p may prove beneficial as a therapeutic strategy for HPS treatment.

摘要

背景/目的:越来越多的证据表明 microRNAs(miRNAs)与肝肺综合征(HPS)有关。本研究旨在探讨 miR-144 在 HPS 血管生成中的作用及其潜在机制。

方法

检测 HPS 大鼠肺微血管内皮细胞(PMVECs)和肺组织中 miR-144-3p 的表达水平。我们预测了 miR-144-3p 的潜在靶基因。Tie2 被鉴定为 miR144-3p 的靶基因,在肺血管的血管生成中起着至关重要的作用。此外,还研究了 miR-144-3p 对 Tie2 的调节作用。miR-144-3p 的上调和下调可以影响 PMVECs 的增殖。

结果

我们发现,miR-144-3p 的水平在 HPS 组织和细胞系中经常下调,miR-144-3p 的过表达显著抑制 PMVECs 的增殖和细胞周期。我们进一步验证了 Tie2 是 HPS 中 miR-144-3p 的一个新的直接靶基因。

结论

miR-144-3p 可以通过 Tie2 表达负调控 PMVECs 的增殖。此外,miR-144-3p 的过表达可能对 HPS 的治疗具有有益作用。

相似文献

1
miR144-3p inhibits PMVECs excessive proliferation in angiogenesis of hepatopulmonary syndrome via Tie2.miR144-3p 通过 Tie2 抑制 PMVECs 在肝肺综合征血管生成中的过度增殖。
Exp Cell Res. 2018 Apr 1;365(1):24-32. doi: 10.1016/j.yexcr.2018.02.009. Epub 2018 Feb 15.
2
MiR145-5p inhibits proliferation of PMVECs via PAI-1 in experimental hepatopulmonary syndrome rat pulmonary microvascular hyperplasia.在实验性肝肺综合征大鼠肺微血管增生中,MiR145 - 5p通过纤溶酶原激活物抑制剂 - 1抑制肺微血管内皮细胞增殖。
Biol Open. 2019 Nov 4;8(11):bio044800. doi: 10.1242/bio.044800.
3
MicroRNA-101 inhibits proliferation of pulmonary microvascular endothelial cells in a rat model of hepatopulmonary syndrome by targeting the JAK2/STAT3 signaling pathway.微小RNA-101通过靶向JAK2/STAT3信号通路抑制肝肺综合征大鼠模型中肺微血管内皮细胞的增殖。
Mol Med Rep. 2015 Dec;12(6):8261-7. doi: 10.3892/mmr.2015.4471. Epub 2015 Oct 22.
4
Hepatocyte-derived exosomal MiR-194 activates PMVECs and promotes angiogenesis in hepatopulmonary syndrome.肝细胞衍生的外泌体 miR-194 激活 PMVECs 并促进肝肺综合征中的血管生成。
Cell Death Dis. 2019 Nov 7;10(11):853. doi: 10.1038/s41419-019-2087-y.
5
MicroRNA-199a-5p Regulates the Proliferation of Pulmonary Microvascular Endothelial Cells in Hepatopulmonary Syndrome.微小RNA-199a-5p调控肝肺综合征中肺微血管内皮细胞的增殖
Cell Physiol Biochem. 2015;37(4):1289-300. doi: 10.1159/000430252. Epub 2015 Oct 5.
6
Requirement of miR-9-dependent regulation of Myocd in PASMCs phenotypic modulation and proliferation induced by hepatopulmonary syndrome rat serum.肝肺综合征大鼠血清诱导的肺动脉平滑肌细胞表型调节和增殖中miR-9依赖性Myocd调控的需求
J Cell Mol Med. 2015 Oct;19(10):2453-61. doi: 10.1111/jcmm.12631. Epub 2015 Jul 6.
7
MiR-206 controls the phenotypic modulation of pulmonary arterial smooth muscle cells induced by serum from rats with hepatopulmonary syndrome by regulating the target gene, annexin A2.微小RNA-206通过调控靶基因膜联蛋白A2来控制肝肺综合征大鼠血清诱导的肺动脉平滑肌细胞表型调节。
Cell Physiol Biochem. 2014;34(5):1768-79. doi: 10.1159/000366377. Epub 2014 Nov 14.
8
MicroRNA-29b-3p inhibits cell proliferation and angiogenesis by targeting VEGFA and PDGFB in retinal microvascular endothelial cells.miRNA-29b-3p 通过靶向视网膜微血管内皮细胞中的 VEGFA 和 PDGFB 抑制细胞增殖和血管生成。
Mol Vis. 2020 Feb 24;26:64-75. eCollection 2020.
9
Long noncoding RNA MALAT1 participates in the pathological angiogenesis of diabetic retinopathy in an oxygen-induced retinopathy mouse model by sponging miR-203a-3p.长链非编码 RNA MALAT1 通过海绵吸附 miR-203a-3p 参与氧诱导的视网膜病变小鼠模型中糖尿病视网膜病变的病理性血管生成。
Can J Physiol Pharmacol. 2020 Apr;98(4):219-227. doi: 10.1139/cjpp-2019-0489. Epub 2019 Nov 5.
10
Loss of cell polarity regulated by PTEN/Cdc42 enrolled in the process of Hepatopulmonary Syndrome.PTEN/Cdc42 调控的细胞极性丧失参与肝肺综合征的发生过程。
J Cell Mol Med. 2019 Aug;23(8):5542-5552. doi: 10.1111/jcmm.14437. Epub 2019 May 29.

引用本文的文献

1
MiR-25-3p regulates pulmonary arteriovenous malformation after Glenn procedure in patients with univentricular heart via the PHLPP2-HIF-1α axis.微小RNA-25-3p通过PHLPP2-HIF-1α轴调控单心室心脏患者格林手术后的肺动静脉畸形。
Sci Rep. 2025 Feb 3;15(1):4138. doi: 10.1038/s41598-025-88840-5.
2
Cholangiocyte-derived exosomal long noncoding RNA PICALM-AU1 promotes pulmonary endothelial cell endothelial-mesenchymal transition in hepatopulmonary syndrome.胆管细胞来源的外泌体长链非编码RNA PICALM-AU1促进肝肺综合征中肺内皮细胞的内皮-间充质转化
Heliyon. 2024 Jan 18;10(3):e24962. doi: 10.1016/j.heliyon.2024.e24962. eCollection 2024 Feb 15.
3
MiR181-5p promotes pathogenic angiogenesis of hepatopulmonary syndrome by negatively regulating Wnt inhibitor Wif1.
微小RNA-181-5p通过负向调控Wnt抑制剂Wif1促进肝肺综合征的病理性血管生成。
Iran J Basic Med Sci. 2023;26(12):1460-1467. doi: 10.22038/IJBMS.2023.70689.15362.
4
MiR26-5p inhibits pathological pulmonary microvascular angiogenesis via down-regulating WNT5A.微小RNA-26-5p通过下调WNT5A抑制病理性肺微血管生成。
Iran J Basic Med Sci. 2023;26(7):812-819. doi: 10.22038/IJBMS.2023.68856.15006.
5
Ginkgolide A Participates in LPS-Induced PMVEC Injury by Regulating miR-224 and Inhibiting p21 in a Targeted Manner.银杏内酯 A 通过靶向调控 miR-224 抑制 p21 参与 LPS 诱导的 PMVEC 损伤。
Contrast Media Mol Imaging. 2022 Sep 10;2022:6384334. doi: 10.1155/2022/6384334. eCollection 2022.
6
Upregulation of miR-144-3p expression attenuates glioma cell viability and invasion by targeting BCL6.miR-144-3p表达上调通过靶向BCL6减弱胶质瘤细胞的活力和侵袭能力。
Exp Ther Med. 2021 Oct;22(4):1157. doi: 10.3892/etm.2021.10591. Epub 2021 Aug 10.
7
Analysis of microRNA expression in peripheral blood monocytes of three Traditional Chinese Medicine (TCM) syndrome types in psoriasis patients.银屑病患者三种中医证型外周血单核细胞中微小RNA表达分析
Chin Med. 2020 May 1;15:39. doi: 10.1186/s13020-020-00308-y. eCollection 2020.
8
Hepatocyte-derived exosomal MiR-194 activates PMVECs and promotes angiogenesis in hepatopulmonary syndrome.肝细胞衍生的外泌体 miR-194 激活 PMVECs 并促进肝肺综合征中的血管生成。
Cell Death Dis. 2019 Nov 7;10(11):853. doi: 10.1038/s41419-019-2087-y.
9
MiR145-5p inhibits proliferation of PMVECs via PAI-1 in experimental hepatopulmonary syndrome rat pulmonary microvascular hyperplasia.在实验性肝肺综合征大鼠肺微血管增生中,MiR145 - 5p通过纤溶酶原激活物抑制剂 - 1抑制肺微血管内皮细胞增殖。
Biol Open. 2019 Nov 4;8(11):bio044800. doi: 10.1242/bio.044800.
10
Krüppel-like factor 6 mediates pulmonary angiogenesis in rat experimental hepatopulmonary syndrome and is aggravated by bone morphogenetic protein 9.Krüppel样因子6介导大鼠实验性肝肺综合征中的肺血管生成,并被骨形态发生蛋白9加重。
Biol Open. 2019 Jun 26;8(6):bio040121. doi: 10.1242/bio.040121.